Loading fund…
Loading fund…
| Returns | 1D | 1M | 3M | YTD | 1Y | 3Y | 5Y | MAX |
|---|---|---|---|---|---|---|---|---|
| Total return | ▲ +1.1% | ▲ +0.1% | ▼ −9.0% | ▲ +3.0% | ▲ +10.6% | ▲ +69.4% | — | ▲ +37.4% |
| Peer average | ▲ +1.2% | ▲ +4.5% | ▲ +9.5% | ▲ +22.6% | ▲ +30.8% | ▲ +76.1% | ▲ +30.8% | — |
| S&P 500 · VOO | ▼ −0.4% | ▲ +0.9% | ▲ +3.3% | ▲ +13.8% | ▲ +13.3% | ▲ +88.8% | ▲ +81.9% | — |
The iShares Neuroscience and Healthcare ETF (IBRN) aims to mirror the financial performance of a particular index. This index consists of companies, both domestically in the U.S. and from other countries, that are expected to benefit from new discoveries and the overall growth in the field of neuroscience.
Distribution yield and SEC yield use different methodologies. Payouts may include income, capital gains, or return of capital.
| Ex-date | Pay date | Per share |
|---|---|---|
| 2025-12-16 | 2025-12-19 | $0.32 |
| 2024-12-17 | 2024-12-20 | $0.10 |
| 2023-12-20 | 2023-12-27 | $0.01 |
| 2023-06-07 | 2023-06-13 | $0.01 |
Estimated annual expense excludes trading costs and assumes constant assets. Fee waivers and fund costs can change.
Historical risk measures describe past behavior and do not predict future returns.
Hear the strategy from the people behind IBRN.